Modification of tumor cells by a low dos
✍
Hansjörg Schild; Paul Hoegen; Volker Schirrmacher
📂
Article
📅
1989
🏛
Springer-Verlag
🌐
English
⚖ 850 KB
Augmented tumor-specific T cell responses were observed against the high metastatic murine lymphoma variant ESb when using as immunogen ESb tumor cells that had been modified by infection with a low dose of Newcastle disease virus (NDV). Such virus-modified inactivated tumor cells (ESb-NDV) were pot